Axon Seminar Cell-based Therapies Wednesday 18 April 2012

The seminar addressed current and future EU legal and regulatory developments relevant to cell-based therapies. In particular, the seminar focused on how to choose and support the right regulatory pathway for a product and seeing that through on a multinational basis.

Speakers and their presentations:

Eliane Schutte, Signifix Advanced Therapy Medicinal Products;

Carine van den Brink, Axon Lawyers Latest Developments in Biotech Patents;

Alex Denoon, Denoon Legal &

Erik Vollebregt, Axon Lawyers Cell Based Therapies Legal & Regulatory

Navigate through our knowledgebase

Related articles

Article

The MDR proposal for extension – “Can the maker repair what he makes?”

On 6 January 2023 it finally happened: the moment that many had been waiting for – the MDR extension proposal finally dropped (see here for Commission provided background). It did not turn…

Read more

Article

The MDR proposal for extension – “Can the maker repair what he makes?”

On 6 January 2023 it finally happened: the moment that many had been waiting for – the MDR extension proposal finally dropped (see here for Commission provided background). It did not turn out to be what I expected in all respects. First, it contained also an amendment to the IVDR: a removal of the sell-off […]

Article

MDR and IVDR outlook for 2023

What to expect for the MDR and IVDR in 2023? Predictions are very hard, especially if they are about the future. That’s a paraphrase of a very solid Danish nugget of wisdom…

Read more